ECFS

Amphotericin

A

MEDICATION TYPE

Antifungal

INDICATIONS

Systemic fungal infections. Oral candidiasis.

DRUG INTERACTIONS

Aminoglycosides
Increased risk of nephrotoxicity.

Corticosteroids
Increases risk of hypokalaemia.

Digoxin
Increased toxicity with hypokalaemia.

Tacrolimus, Cyclosporin
Increases risk of nephrotoxicity.

NOTES

Liposomal formulation (AmBisome®) preferred for reduced nephrotoxicity.

Unverified — pending review

MEDICAL WARNING

Amphotericin should only be administered under the supervision of a healthcare professional. Always verify against current BNF and your local CF protocol before prescribing.